2 citations
,
April 2021 in “Naukovì gorizonti” In this study, researchers observed that using a combination of medications, including Bravecto, Cefuroxime, Orungal, Apoquel, and Derinat, effectively treated pododermatitis in dogs, increasing therapy success from 28.6% to 66.7%, and reducing treatment duration while extending remission periods.
January 2025 in “International Journal of Biology Sciences” In this case study, a 10-month-old Doberman with generalized demodicosis recovered fully after treatment with a combination of systemic and topical therapies, including ivermectin, hydroxyzine, enrofloxacin, fluralaner, and specialized shampoos.
January 2025 in “International Journal of Advanced Biochemistry Research” In this study, dogs diagnosed with demodicosis achieved full recovery after a single dose of fluralaner, with clinical improvement supported by negative skin scraping results by day 28, and hematobiochemical parameters normalizing over the treatment period.
January 2024 in “International journal of advanced biochemistry research” This case study reported that a one-year-old male dog with demodicosis successfully recovered after treatment with Bravecto (fluralaner) and supportive therapies, highlighting the importance of recognizing and managing Demodex canis infections in dogs.
January 2024 in “International journal of advanced biochemistry research” This study observed eight dogs with severe itching, hair loss, and skin lesions that had not responded to previous treatments. After treating the dogs with fluralaner, antibiotics, immune boosters, and omega supplements, partial recovery was seen in one month, with full recovery in two months.